Roche is acquiring Poseida Therapeutics, a biotech developing allogeneic cell therapies for cancers and immunological indications. The two companies have been partners in hematological malignancies since 2022. The post Roche Expands Its Scope in Allogeneic Cell Therapy With $1B Poseida Therapeutics Acquisition appeared first on MedCity News.
Eli Lilly now offers vials of obesity medication Zepbound directly to self-pay patients at a nearly 50% discount off the drug’s list price. But more than offering patients a lower-cost alternative, this move represents a strategic stance against certain pharmaceutical industry players. The post With Direct-to-Patient Zepbound, Eli Lilly Takes a Stand Against Compounders and…
This analysis, based on findings from the 2024 KFF Women’s Health Survey, focuses on women with children ages 5 & under and their perceptions on how easy or difficult they feel it is to access a range of services that are important to the health of women and families, including maternity care, Medicaid coverage, food…
[Sponsored] Here are some of the top online health insurance options worth exploring — each designed to simplify coverage decisions while meeting California’s high standards for accessibility and compliance. The post Shop and Compare: Online Health Insurance Options in California appeared first on MedCity News.
As always, this year’s HLTH conference brought a slew of announcements — from product launches to funding rounds to new partnerships. This list features short summaries for seven of the conference’s most notable announcements. The post 7 HLTH Announcements You Don’t Want to Miss appeared first on MedCity News.
Through Evvy’s vaginal microbiome test, consumers can now receive insights on fertility. The vaginal microbiome is often overlooked when it comes to fertility, according to Priyanka Jain, CEO and co-founder of Evvy. The post Evvy Launches Fertility Insights Offering Via Vaginal Microbiome Test appeared first on MedCity News.
Qure.ai — which is headquartered in India — closed a $65 million Series D financing round. When asked whether the startup is thinking about a public exit anytime soon, CEO Prashant Warie said that for now, the company’s focusing is on continuing to build its market globally and “venturing deeper into meeting the healthcare challenges…
The high dose of Eli Lilly’s retatrutide led to an average 28.7% loss in body weight measured at 68 weeks. These Phase 3 results are the first from the experimental obesity drug’s broad clinical trial program, which is on track to yield seven data readouts in the coming year. The post Eli Lilly Drug for…
Matt Chance and Will Robinson discuss some of the ways LEAD builds on their experience in the high-needs track of the ACO REACH model, which ends in 2026
[Sponsored] Temperature-sensitive medications represent one of the most critical operational and regulatory challenges in modern pharmacy management. The post Best Automated Systems for Cold Chain Pharmacy Management appeared first on MedCity News.